Attovia
PrivateLast Round
Series C
Apr 15, 2025
Total Funding Raised
$315M
Company Overview
Attovia is a biopharmaceutical company focused on developing a pipeline of biotherapeutics aimed at treating immune-mediated diseases and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Attovia Comps
Public and private peers based on sector, stage, and business model.
Attovia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 15, 2025 | ||||
| Series B | May 9, 2024 | ||||
| Series A | Feb 8, 2024 | ||||
| Series A | Jun 20, 2023 |
Key People
Founding team and executive leadership
Attovia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series C, Series B |
| Redmile Group | Series B |
| Mirae Asset | Series C |
| Vida Ventures | Series C |
| Deep Track Capital | Series C |
| Frazier Life Sciences | Series C, Series B, Series A |
| Logos Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2025
Partnered with SciNeuro Pharmaceuticals on a neurology target.
- Apr 15, 2025
$90M round raised.
Attovia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Attovia's valuation, stock price, and market status.
